sodium selenite has been researched along with Uterine Cervical Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Du, L; Feng, C; Hao, S; Jablonska, E; Jia, Y; Jiang, M; Li, G; Li, Q; Qi, L; Su, S; Sun, H; Wang, M; Wang, R; Wang, T; Wang, Y | 1 |
| Dvořák, V; Grandjean, EM; Major, AL; Malík, T; Mayboroda, I; Pluta, M; Schwarzová, J; Skřivánek, A | 1 |
| Adamietz, IA; Baaske, D; Berndt-Skorka, R; Buentzel, J; Eich, HT; Glatzel, M; Huebner, J; Kisters, K; Kundt, G; Micke, O; Muecke, R; Prott, FJ; Reichl, B; Schaefer, U; Schomburg, L | 1 |
| Adamietz, IA; Buentzel, J; Eich, HT; Fakhrian, K; Glatzel, M; Huebner, J; Kisters, K; Micke, O; Muecke, R; Reichl, B; Schaefer, U; Schomburg, L | 1 |
| Baaske, D; Berndt-Skorka, R; Bruns, F; Buentzel, J; Devries, A; Glatzel, M; Kisters, K; Kundt, G; Micke, O; Muecke, R; Prott, FJ; Reichl, B; Schaefer, U; Schomburg, L; Stoll, G; Willich, N | 1 |
| Fu, L; Liu, Q; Shen, L; Wang, Y | 1 |
| Cerman, J; Cervinka, M; Radocha, J; Rudolf, E | 1 |
4 trial(s) available for sodium selenite and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
Efficacy and safety of an adsorbent and anti-oxidative vaginal gel on CIN1 and 2, on high-risk HPV, and on p16/Ki-67: a randomized controlled trial.
Topics: Administration, Intravaginal; Adult; Antioxidants; Biomarkers, Tumor; Citric Acid; Colposcopy; Cyclin-Dependent Kinase Inhibitor p16; Cytodiagnosis; Female; Genes, p16; Humans; Ki-67 Antigen; Middle Aged; Papillomavirus Infections; Pregnancy; Silicon Dioxide; Sodium Selenite; Treatment Outcome; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Creams, Foams, and Jellies; Vaginal Smears | 2021 |
Impact of treatment planning target volumen (PTV) size on radiation induced diarrhoea following selenium supplementation in gynecologic radiation oncology--a subgroup analysis of a multicenter, phase III trial.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Diarrhea; Dietary Supplements; Female; Humans; Middle Aged; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Selenium; Sodium Selenite; Uterine Cervical Neoplasms | 2013 |
Multicenter, phase III trial comparing selenium supplementation with observation in gynecologic radiation oncology: follow-up analysis of the survival data 6 years after cessation of randomization.
Topics: Adult; Aged; Aged, 80 and over; Diarrhea; Dietary Supplements; Disease-Free Survival; Female; Follow-Up Studies; Humans; Middle Aged; Radiation Injuries; Radiotherapy, Adjuvant; Selenium; Sodium Selenite; Survival Rate; Time Factors; Uterine Cervical Neoplasms; Uterine Neoplasms | 2014 |
Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology.
Topics: Adult; Aged; Aged, 80 and over; Diarrhea; Female; Germany; Humans; Middle Aged; Radiotherapy; Selenium; Sodium Selenite; Time Factors; Uterine Cervical Neoplasms; Uterine Neoplasms | 2010 |
3 other study(ies) available for sodium selenite and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
Sodium selenite inhibits cervical cancer growth via ROS mediated AMPK/FOXO3a /GADD45a axis.
Topics: Adenosine; Adenosine Monophosphate; AMP-Activated Protein Kinases; Animals; Apoptosis; Cell Cycle Proteins; Female; Forkhead Box Protein O3; Forkhead Transcription Factors; HeLa Cells; Humans; Mice; Mice, Nude; Reactive Oxygen Species; RNA; Selenium; Sodium Selenite; Trace Elements; Uterine Cervical Neoplasms | 2022 |
Proteomic study on sodium selenite-induced apoptosis of human cervical cancer HeLa cells.
Topics: Apoptosis; Blotting, Western; Cell Shape; Cell Survival; Electrophoresis, Gel, Two-Dimensional; Female; HeLa Cells; Humans; Membrane Potential, Mitochondrial; Neoplasm Proteins; Proteomics; Reactive Oxygen Species; Sodium Selenite; Uterine Cervical Neoplasms | 2011 |
Combined effect of sodium selenite and campthotecin on cervical carcinoma cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Camptothecin; Carcinoma; Caspase 3; Caspases; Cell Division; Cell Line, Tumor; Cell Nucleus; DNA Fragmentation; Dose-Response Relationship, Drug; Enzyme Activation; Female; HeLa Cells; Humans; Mitochondria; Oxidative Stress; Sodium Selenite; Time Factors; Uterine Cervical Neoplasms | 2004 |